Industry > Industry monitor > Healthcare
29 April 2021
Ayush 64, a poly-herbal preparation originally developed by the Central Council for Research in Ayurvedic Sciences (CCRAS) for the treatment of Malaria, in the year 1980 and now repurposed for the treatment Covid-19, has been found to be useful in the treatment of asymptomatic, mild and moderate Covid-19 infection as an adjunct to standard care.
Ministry of Ayush and the Council of Scientific and Industrial Research (CSIR) recently collaborated for robust multi-centre clinical trials to evaluate the safety and efficacy of Ayush 64 in the management of mild to moderate Covid-19 patients.
Clinical trials were conducted at KGMU, Lucknow; DMIMS, Wardha and BMC Covid Centre, Mumbai, involving 70 participants in each arm. Dr Chopra said Ayush 64 as an adjunct to standard of care (SoC) showed significant improvement and thus lesser period of hospitalisation compared to the only SoC procedure, Dr Arvind Chopra, director, Centre for R